6 Einträge gefunden

1. Post-Transplantation Multicolored Flow Cytometry-Minimal Residual Disease Status on Day 100 Predicts Outcomes for Patients With Refractory Acute Myeloid Leukemia

   1. Klyuchnikov, Evgeny
   2. Badbaran, Anita
   3. Massoud, Radwan
   4. Fritsche-Friedland, Ulrike
   5. Janson, Dietlinde
   6. Ayuk, Francis
   7. Christopeit, Maximilian

   2022 - Forschungsinformationssystem des UKE
2. Post-Transplantation Day +100 Minimal Residual Disease Detection Rather Than Mixed Chimerism Predicts Relapses after Allogeneic Stem Cell Transplantation for Intermediate-Risk Acute Myelogenous Leukemia Patients Undergoing Transplantation in Complete Remission

   1. Klyuchnikov, Evgeny
   2. Badbaran, Anita
   3. Massoud, Radwan
   4. Fritzsche-Friedland, Ulrike
   5. Freiberger, Petra
   6. Ayuk, Francis
   7. Wolschke, Christine

   2022 - Forschungsinformationssystem des UKE
3. Role of pre-transplant MRD level detected by flow cytometry in recipients of allogeneic stem cell transplantation with AML

   1. Klyuchnikov, Evgeny
   2. Christopeit, Maximilian
   3. Badbaran, Anita
   4. Bacher, Ulrike
   5. Fritsche-Friedland, Ulrike
   6. von Pein, Ute-Marie
   7. Wolschke, Christine

   2021 - Forschungsinformationssystem des UKE
4. Enhanced Immune Reconstitution of γδ T Cells after Allogeneic Stem Cell Transplantation Overcomes the Negative Impact of Pretransplantation Minimal Residual Disease-Positive Status in Patients with Acute Myelogenous Leukemia

   1. Klyuchnikov, Evgeny
   2. Badbaran, Anita
   3. Massoud, Radwan
   4. Fritsche-Friedland, Ulrike
   5. Janson, Dietlinde
   6. Ayuk, Francis
   7. Wolschke, Christine

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
5. Postallogeneic monitoring with molecular markers detected by pretransplant next-generation or Sanger sequencing predicts clinical relapse in patients with myelodysplastic/myeloproliferative neoplasms

   1. Fu, Yuewen
   2. Schroeder, Thomas
   3. Zabelina, Tatiana
   4. Badbaran, Anita
   5. Bacher, Ulrike
   6. Kobbe, Guido
   7. Ayuketang, Francis Ayuk

   2014 - Forschungsinformationssystem des UKE
6. Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells.

   1. Lioznov, Michael
   2. El-Cheikh, J
   3. Hoffmann, Friedericke
   4. Hildebrandt, York
   5. Ayuketang Ayuk, Francis
   6. Wolschke, Christine
   7. Atanackovic, Djordje

   2009 - Forschungsinformationssystem des UKE